To understand where gout is most common around the world and why, let’s break it down in a way that’s easy to grasp.

What is Gout?

Gout is a type of arthritis, which is a condition that causes pain and swelling in the joints. It happens when there is too much uric acid in the blood. Uric acid is a substance that forms when the body breaks down purines, which are found in certain foods and drinks. When there is too much uric acid, it can form sharp crystals in the joints, leading to the painful symptoms of gout.

Where is Gout Most Common?

Gout is found all over the world, but some areas have more cases than others. Here are some regions where gout is particularly common:

1. North America: In countries like the United States, gout is quite common. This is partly because of the diet and lifestyle, which often includes foods and drinks high in purines, like red meat and sugary beverages.
2. East Asia: Countries like China and Japan have seen an increase in gout cases. This rise is linked to changes in diet and lifestyle as these countries become more developed.
3. Pacific Islands: In places like New Zealand, especially among the Maori population, gout is more prevalent. This is due to genetic factors and dietary habits.
4. Europe: Some parts of Europe also report high cases of gout, particularly in countries with diets rich in meat and alcohol.

Why is Gout More Common in These Areas?

Several factors contribute to the high prevalence of gout in these regions:

1. Diet: A diet high in purines can lead to higher levels of uric acid. Foods like red meat, seafood, and sugary drinks are rich in purines. In many developed countries, these foods are consumed frequently, leading to more cases of gout.
2. Lifestyle: Sedentary lifestyles, where people do not get enough physical activity, can contribute to obesity, which is a risk factor for gout. Many people in developed countries have jobs that require sitting for long periods, and they may not exercise enough.
3. Genetics: Some populations have a genetic predisposition to gout. This means that they are more likely to develop the condition due to their genetic makeup. For example, the Maori people in New Zealand have a higher genetic risk for gout.
4. Obesity: Being overweight or obese increases the risk of developing gout. This is because more body fat can lead to higher levels of uric acid. In many developed countries, obesity rates are high, which correlates with higher gout cases.
5. Alcohol Consumption: Drinking alcohol, especially beer, can increase uric acid levels. In regions where alcohol consumption is high, there are often more cases of gout.
6. Age and Gender: Gout is more common in men than in women, and it often develops in middle age. However, after menopause, women’s risk increases. This pattern is seen globally.

How Can Gout Be Managed?

While gout can be painful, it is manageable with the right approach:

1. Dietary Changes: Reducing the intake of purine-rich foods can help lower uric acid levels. This means eating less red meat and seafood and avoiding sugary drinks and alcohol.
2. Weight Management: Maintaining a healthy weight through diet and exercise can reduce the risk of gout attacks.
3. Medication: There are medications available that can help lower uric acid levels and manage pain during gout attacks.
4. Hydration: Drinking plenty of water can help flush uric acid from the body.
5. Regular Check-Ups: Regular visits to a healthcare provider can help monitor uric acid levels and adjust treatment as needed.

Conclusion

Gout is a common condition that affects many people worldwide, particularly in regions with diets high in purines and sedentary lifestyles. Understanding the factors that contribute to gout can help in managing and preventing it. By making lifestyle changes and seeking medical advice, individuals can reduce their risk of gout and manage its symptoms effectively.

Bibliography:

Ahn, J. (2023). Epidemiology and treatment-related concerns of gout and hyperuricemia in Korean. Journal of Rheumatic Diseases, 30, 88–98.

Al-Allaf, A., & Rheumatologist, C. (1970). Gout: evidence based update with new therapeutic strategies. Sudan Medical Journal.

Alderman, M. (2007). Uric Acid , and Cardiovascular Disease.

AlQahtani, A., Alim, B. M., Almudhaibery, F. S., Mulafikh, D., Almutairi, S., Almohanna, S., & Alfawwaz, F. S. (2022). The Impact of Climatic, Socioeconomic, and Geographic Factors on the Prevalence of Allergic Fungal Rhinosinusitis: A Worldwide Ecological Study. American Journal of Rhinology & Allergy, 36, 423–431.

Araujo Dantas, A. B., Gonçalves, F., Martins, A., Santos Alves, G. Â., Stechman-Neto, J., Corrêa, C., Santos, R., Nascimento, W., Araújo, C. M., & Taveira, K. V. M. (2023). Worldwide prevalence and associated risk factors of obstructive sleep apnea: a meta-analysis and meta-regression. Sleep and Breathing, 27, 2083–2109.

Barbadoro, P., Luciani, A., Ciotti, M., D’Errico, M., & Group, O. B. O. T. A. W. C. (2020). Two-Source Capture-Recapture Method to Estimate the Incidence of Acute Flaccid Paralysis in the Marches Region (Italy). International Journal of Environmental Research and Public Health, 17.

Bardin, T., & Richette, P. (2017). Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Medicine, 15.

Barskova, V. G., & Mukagova, M. V. (2011). Современные представления о патогенезе и методах коррекции уратного нефролитиаза у больных подагрой. Modern Rheumatology Journal, 5, 39–43.

Bozio, P. M. C., Ujamaa, M. D., Dawood, M. F. S., Chai, M. M. S., Kirley, M. P. D., Alden, M. N. B., Austin, M. E., Desiato, M. J., Yousey-Hindes, M. K., EmilyFawcett, M., KyleP.Openo, M., MayaMonroe, M., PatriciaA.Ryan, M., Science Anna Falkowski, M., Kim, M. S., eld, M. R. L., McMahon, M. M., Angeles, M. K., Khanlian, M. S., … Garg, M. S. (2023). 2614. Trends in characteristics of influenza-associated hospitalizations among pregnant women, FluSurv-NET 2015-2016 through 2022-2023 seasons. Open Forum Infectious Diseases, 10.

Broström, A., Alimoradi, Z., Lind, J., Ulander, M., Lundin, F., & Pakpour, A. (2023). Worldwide estimation of restless legs syndrome: a systematic review and meta‐analysis of prevalence in the general adult population. Journal of Sleep Research, 32.

Buckley, H. (2011). Epidemiology of Gout: Perspectives from the Past. Current Rheumatology Reviews, 7, 106–113.

Celermajer, D. (2017). Eisenmenger syndrome: a rare malady that continues to fascinate. European Heart Journal, 38, 2068–2069.

Cheremushkina, E., Eliseev, M., Severinova, M., & Zhelyabina, O. (2023). Sonography as method for diagnosing gout at preclinical stage (preliminary data from pilot study). Medical Alphabet.

Chiarotti, F., & Venerosi, A. (2020). Epidemiology of Autism Spectrum Disorders: A Review of Worldwide Prevalence Estimates Since 2014. Brain Science, 10.

Chikina, M., Ilyinykh, E., & Eliseev, M. (2020). Adherence to urate-lowering therapy while following the national guidelines for the management of patients with gout (preliminary evidence). Modern Rheumatology Journal, 14, 70–75.

Chua, C., & Thong, B. (2021). Inflammatory Arthritis Among Military Servicemen From a Rheumatology Center in Singapore. Military Medicine.

Dehlin, M., Drivelegka, P., Sigurdardottir, V., Svärd, A., & Jacobsson, L. (2016a). Incidence and prevalence of gout in Western Sweden. Arthritis Research & Therapy, 18.

Dehlin, M., Drivelegka, P., Sigurdardottir, V., Svärd, A., & Jacobsson, L. (2016b). THU0522 Increasing Incidence of Gout in Western Sweden – A Register Study. Annals of the Rheumatic Diseases, 75, 381–381.

Denova, L. D. (2023). The effect of antioxidant therapy on the course of predialysis chronic kidney disease in a patient with comorbidity. KIDNEYS.

Donzelli, A., Battaggia, A., & Schivalocchi, A. (2017). Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies. Osteoporosis International, 28, 2739–2740.

Dp, M. (1992). [Changes in the epidemiology, symptomatology and prognosis of gout]. Versicherungsmedizin / Herausgegeben von Verband Der Lebensversicherungs-Unternehmen e.V. Und Verband Der Privaten Krankenversicherung e.V, 44, 10–13.

Egami, T., & Ryu, C. W. (2023). Origin of medium-range atomic correlation in simple liquids: Density wave theory. AIP Advances.

Fernández‐Cruz, A., Menárguez, M. C., Muñoz, P., Pedromingo, M., Peláez, T., Solís, J., Rodrı́guez-Créixems, M., Bouza, E., & group. (2015). The search for endocarditis in patients with candidemia: a systematic recommendation for echocardiography? A prospective cohort. European Journal of Clinical Microbiology and Infectious Diseases, 34, 1543–1549.

Freeman, E. (1902). THREE CASES OF CEREBRO-SPINAL FEVER TREATED WITH ANTIPYRIN. British Medical Journal, 1, 1262–1263.

Furuichi, K., Shimizu, M., Yuzawa, Y., Hara, A., Toyama, T., Kitamura, H., Suzuki, Y., Sato, H., Uesugi, N., Ubara, Y., Hoshino, J., Hisano, S., Ueda, Y., Nishi, S., Yokoyama, H., Nishino, T., Kohagura, K., Ogawa, D., Mise, K., … Nephros. (2018). Nationwide multicenter kidney biopsy study of Japanese patients with hypertensive nephrosclerosis. Clinical and Experimental Nephrology, 22, 629–637.

Geedigunta, V., Khan, Z., Bachan, M., Latef, S., Eshak, D., & Dosala, S. (2022). A Unique Case of Pneumocystis Jirovecii (PCP) Pneumonia in HIV- Uninfected, COVID -19 Positive Patient. C61. BREAKING THE MOLD.

Gelsomino, M., & Tamborrini, G. (2014). [Treatment resistant polyarthritis]. Praxis, 103 14, 841–844.

Gill, D., Daniel, R., Halpern, L., & Southerland, J. (2016). A Giant Submandibular Sialolith in the Setting of Chronic Sialodenitis : A Case Report and Literature Review.

Giorgi, A. D., Fabbian, F., Pala, M., Tiseo, R., Parisi, C., Misurati, E., & Manfredini, R. (2015). Uric acid: friend or foe? Uric acid and cognitive function “Gout kills more wise men than simple”. European Review for Medical and Pharmacological Sciences, 19 4, 640–646.

Guizzardi, G., & Guarino, N. (2023). Semantics, Ontology and Explanation. arXiv.Org, abs/2304.11124.

Gupta, R. S., Koteci, A., Morgan, A., George, P., & Quint, J. (2023). Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review. BMJ Open Respiratory Research, 10.

Gupta, S., Yui, J., Xu, D., Fitzhugh, C., Clark, C., Siddiqui, S., Conrey, A. K., Kato, G., & Minniti, C. (2015). Gout and sickle cell disease: not all pain is sickle cell pain. British Journal of Haematology, 171.

Hameed, M., Turkiewicz, A., Englund, M., Jacobsson, L., & Kapetanovic, M. (2019). Prevalence and incidence of non-gout crystal arthropathy in southern Sweden. Arthritis Research & Therapy, 21.

Hancuh, M., Walldorf, J., Minta, A. A., Tévi-Bénissan, C., Christian, K., Nedelec, Y., Heitzinger, K., Mikoleit, M., Tiffany, A., Bentsi-Enchill, A., & Breakwell, L. (2023). Typhoid Fever Surveillance, Incidence Estimates, and Progress Toward Typhoid Conjugate Vaccine Introduction — Worldwide, 2018–2022. MMWR. Morbidity and Mortality Weekly Report, 72, 171–176.

Hazlina, N. H. N., Norhayati, M. N., Bahari, I. S., & Arif, N. A. N. M. (2022). Worldwide prevalence, risk factors and psychological impact of infertility among women: a systematic review and meta-analysis. BMJ Open, 12.

He, Q., Mok, T., Sin, T.-H., Yin, J., Li, S., Yin, Y., Ming, W., & Feng, B. (2023). Global, Regional, and National Prevalence of Gout From 1990 to 2019: Age-Period-Cohort Analysis With Future Burden Prediction. JMIR Public Health and Surveillance, 9.

Hor, J. Y., Asgari, N., Nakashima, I., Broadley, S., Leite, M., Kissani, N., Jacob, A., Marignier, R., Weinshenker, B., Paul, F., Pittock, S., Palace, J., Wingerchuk, D., Behne, J., Yeaman, M., & Fujihara, K. (2020). Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Frontiers in Neurology, 11.

Hor, J. Y., & Fujihara, K. (2023). Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide. Frontiers in Neurology, 14.

Huang, J., Chan, W. C., Ngai, C., Lok, V., Zhang, L., Lucero‐Prisno, D., Xu, W., Zheng, Z., Elcarte, E., Withers, M., Wong, M. C. S., & A, O. B. O. N. G. H. R. G. O. (2022). Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers, 14.

Ijms, E. B. (2022). Abstracts of the Medical Academical Conference of Piauí (COMAPI) 2021. International Journal of Medical Studies.

Iqbal, U., Siddiqui, H. U., Anwar, H., Chaudhary, A., & Quadri, A. (2017). Allopurinol-Induced Granulomatous Hepatitis: A Case Report and Review of Literature. Journal of Investigative Medicine High Impact Case Reports, 5.

Jiang, J., Zhang, T., Liu, Y., Chang, Q., Zhao, Y., Guo, C., & Xia, Y. (2023). Prevalence of Diabetes in Patients with Hyperuricemia and Gout: A Systematic Review and Meta-analysis. Current Diabetes Reports, 23, 103–117.

Jiang, L., Chen, S., Wu, Y., Zhou, D., & Duan, L. (2023). Prediction of coronary heart disease in gout patients using machine learning models. Mathematical Biosciences and Engineering : MBE, 20 3, 4574–4591.

Johnson, G. (1873). Lectures on the Pathology, Diagnosis, and Treatment of Bright’s Disease. British Medical Journal, 1, 725–726.

Kancherla, V. (2023). Neural tube defects: a review of global prevalence, causes, and primary prevention. Child’s Nervous System, 1–8.

Kawamura, Y., Nakaoka, H., Nakayama, A., Okada, Y., Yamamoto, K., Ooyama, H., Stibůrková, B., Merriman, T., Nakatochi, M., Wakai, K., Kubo, M., Ichida, K., Shinomiya, N., & Matsuo, H. (2019). OP0047 A GENOME-WIDE ASSOCIATION STUDY IDENTIFIED NOVEL LOCI ASSOCIATED WITH THE PROGRESSION FROM ASYMPTOMATIC HYPERURICEMIA TO GOUT. Oral Presentations, 78, 94–95.

Klerk, E., Heijde, D. M., Tempel, H., & Linden, S. (1999). Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy. Journal of Rheumatology, 26 12, 2635–2641.

Knowledge, Attitude and Practices Assessment of the Gout Patients Residing in Lahore, Pakistan. (2022). Pakistan Journal of Medicine and Dentistry.

Kodio, B., Pamanta, I., Sylla, C., Kayentao, K., Dolo, H., & Cissé, I. (2015). Step wise approach of gout in the rheumatology ward of Point-G University Teaching Hospital of Bamako, Mali. 3, 22–26.

Koto, R., Nakajima, A., Horiuchi, H., & Yamanaka, H. (2019). FRI0678 PREVALENCE, PATIENT CHARACTERISTICS, AND TREATMENT OF GOUT AND ASYMPTOMATIC HYPERURICEMIA IN JAPAN: CROSS-SECTIONAL STUDY OF A HEALTH INSURANCE CLAIMS DATABASE. Epidemiology, Risk Factors for Disease or Disease Progression, 78, 1037–1037.

Kuo, C., Grainge, M., See, L., Yu, K.-H., Luo, S., Zhang, W., & Doherty, M. (2015). Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Research & Therapy, 17.

Lee, E., Knox, C., & Phillips, E. (2023). Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. JAMA Dermatology.

Lee, J., Lee, J. S., Chung, M., Ahn, J., Choi, H., Hong, S.-J., Yoon, C., Kim, S.-H., Jeong, K.-H., Kim, J.-W., Kim, B.-Y., Shin, J., Kim, W., Kim, S., Kim, H.-J., Song, J.-S., Jun, J.-B., Park, H.-A., Chae, S., … Kim, H. A. (2023). Korean guidelines for the management of gout. Journal of Rheumatic Diseases, 30, 141–150.

Lerma, O., Kosheleva, O., & Kreinovich, V. (2014). A Simple Geometric Model Provides a Possible Quantitative Explanation of the Advantages of Immediate Feedback in Student Learning.

Li, F., Qin, W., Zhu, M., & Jia, J. (2021). Model-Based Projection of Dementia Prevalence in China and Worldwide: 2020-2050. Journal of Alzheimer’s Disease.

Li, H., Nie, D., Wang, S., Li, D., & Liu, C.-H. (2021). Clinical value of turbidity-elimination gout soup combined with external application of traditional chinese medicine to improve the pain and the volume of tophi in patients with gout. Food Science and Technology International.

Maggioni, A., Rossi, E., Cinconze, E., Roggeri, D., Roggeri, A., Fabbri, G., Rosa, M., & Arno Cardiovascular Observatory. (2013). Outcomes, Health Costs and Use of Antiplatelet Agents in 7,082 Patients Admitted for an Acute Coronary Syndrome Occurring in a Large Community Setting. Cardiovascular Drugs and Therapy, 27, 333–340.

Martínez-Martínez, M., Román-Acosta, S., Alvarez-Reyes, J., Oros-Ovalle, C., & Abud-Mendoza, C. (2013). [Calciphylaxis, renal failure and gout. A patient with hyperuricemia as a risk factor for death]. Revista Medica Del Instituto Mexicano Del Seguro Social, 51 2, 218–221.

Mattiuzzi, C., & Lippi, G. (2019). Recent updates on worldwide gout epidemiology. Clinical Rheumatology, 39, 1061–1063.

Mémin, Y., Monville, C., & Ryckewaert, A. (1978). [Articular chondrocalcinosis after 80 years of age]. Revue Du Rhumatisme et Des Maladies Osteo-Articulaires, 45 2, 77–82.

Mertz, D. (1992). [Changes in the epidemiology, symptomatology and prognosis of gout]. Versicherungsmedizin, 44 1, 10–13.

Mittal, G., Oncologist, S., Manjunath, S., Naik, B. N., Deb, S., & Pathology, O. (2020). Clinico-pathological co-relation using various immuno-histochemistry markers likeER, PR, HER-2 NEU, CK5/6, EGFR, KI-67 in carcinoma breast. 5, 30–34.

Moorthie, S., Blencowe, H., Darlison, M. W., Lawn, J., Morris, J., Modell, B., Bittles, A., Blencowe, H., Christianson, A., Cousens, S., Darlison, M. W., Gibbons, S., Hamamy, H., Khoshnood, B., Howson, C., Lawn, J., Mastroiacovo, P., Modell, B., Moorthie, S., … Yunnis, K. A. (2018). Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide. Journal of Community Genetics, 9, 387–396.

Nicholson, P., Saunsbury, E., D’Angelo, S., Churchill, D., & Walker-Bone, K. (2018). Prevalence of and risk factors for gout in HIV-positive adults: A case–control study. International Journal of STD and AIDS, 30, 249–255.

Nkeck, J., Singwé-Ngandeu, M., Moor, V., Chedjou, J.-P., Doualla, M., & Mbacham, W. (2017). Evaluation of Oxidative Status of Patients with Gout Attack in a Cameroonian Urban Hospital. Open Journal of Rheumatology and Autoimmune Diseases, 07, 111–119.

Parchami-Araghi, A., Bohle, M., Rao, S., & Schiele, B. (2024). Good Teachers Explain: Explanation-Enhanced Knowledge Distillation. arXiv.Org, abs/2402.03119.

Pillinger, M., & Abeles, A. (2010). Such Sweet Sorrow: Fructose and the Incidence of Gout. Current Rheumatology Reports, 12, 77–79.

Pirog, E., Lloveras, B., Molijn, A., Tous, S., Guimerà, N., Alejo, M., Clavero, O., Klaustermeier, J., Jenkins, D., Quint, W., Bosch, F., Alemany, L., & Sanjosé, S. (2014). HPV prevalence and genotypes in different histological subtypes of cervical adenocarcinoma, a worldwide analysis of 760 cases. Modern Pathology, 27, 1559–1567.

Pukdee, R., Sam, D., Kolter, J. Z., Balcan, M.-F., & Ravikumar, P. (2023). Learning with Explanation Constraints. Neural Information Processing Systems, abs/2303.14496.

Rachina, S., Kozlov, R., Kurkova, A., Portnyagina, U., Palyutin, S., Khokhlov, A., Reshetko, O., Zhuravleva, M., Palagin, I., & Project, O. B. O. R. W. G. O. T. (2022). Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic. Antibiotics, 11.

Rana, A., D’Addio, R. M., Manzato, M., & Bridge, D. (2022). Extended recommendation-by-explanation. User Modeling and User-Adapted Interaction, 32, 91–131.

Ransome, A. (1883). Progressive Pernicious Anæmia: A Case, with Remarks*. British Medical Journal, 1, 1112–1113.

Redondo-Rodriguez, R., Mena-Vázquez, N., Cabezas-Lucena, A. M., Manrique-Arija, S., Mucientes, A., & Fernández-Nebro, A. (2022). Systematic Review and Metaanalysis of Worldwide Incidence and Prevalence of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis. Journal of Clinical Medicine, 11.

Rees, F., Doherty, M., Grainge, M., Lanyon, P., & Zhang, W. (2017). The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology, 56, 1945–1961.

Roman, Y. M., Tiirikainen, M., & Prom-Wormley, E. (2020). The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort. Clinical Rheumatology, 39, 2387–2392.

Russell, E., & Checa, A. (2013). Potential pitfalls in the diagnosis of crystal-induced arthritis and in the sonographic measurement of hyaline cartilage due to the presence of joint effusion. Journal of Clinical Rheumatology, 19 2, 98–100.

Saunsbury, E., Mahendran, P., Youssef, E., Churchill, D., Roddy, E., Packham, J., Obrenovic, K., & Ledingham, J. (2014). PREVALENCE OF AND RISK FACTORS FOR GOUT IN THE HIV-INFECTED POPULATION.

Sigurdsson, E. (2013). Up and running: An underutilized prescription in primary care. Scandinavian Journal of Primary Health Care, 31, 1–2.

Singh, G., Lingala, B., & Mithal, A. (2019a). Gout and hyperuricaemia in the USA: prevalence and trends. Rheumatology.

Singh, G., Lingala, B., & Mithal, A. (2019b). SAT0405 GOUT AND HYPERURICEMIA IN THE US: PREVALENCE AND TRENDS. Saturday, 15 June 2019, 78, 1290–1290.

Sparks, S., Vang, P. C., Peterman, B., Moua, M., & Phillips, L. (2014). Commentary: Utilizing Community-Engaged Approaches to Investigate and Address Hmong Women’s Cancer Disparities. Hmong Studies Journal, 15, 1–18.

Sriboonchitta, S., & Kreinovich, V. (2018). Why Are FGM Copulas Successful? A Simple Explanation. Advances in Fuzzy Systems, 2018, 5872195:1-5872195:5.

Teng, M., Ng, C., Huang, D. Q., Chan, K., Tan, D. J. H., Lim, W., Yang, J. D., Tan, E., & Muthiah, M. (2022). Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology, 29, S32–S42.

The, W. C. O. T. R. O. C. H. A. (2023). Report on Cardiovascular Health and Diseases in China 2022: an Updated Summary. Biomedical and Environmental Sciences : BES, 36 8, 669–701.

Ting, K., Gill, T., Keen, H., Tucker, G. R., & Hill, C. (2016). Prevalence and associations of gout and hyperuricaemia: results from an Australian population‐based study. Internal Medicine Journal (Print), 46.

Urban, M. (2016). 17. Motivation by formally analyzable terms in a typological perspective: An assessment of the variation and steps towards explanation.

Utkin, L., Meldo, A., Kovalev, M., & Kasimov, E. (2020). A Simple General Algorithm for the Diagnosis Explanation of Computer-Aided Diagnosis Systems in Terms of Natural Language Primitives. System Configuration Management, 202–205.

Vinotha, T. (2015). Association of High Serum Uric Acid Levels in Chronic Liver Disease.

Watson, C. (1905). REASONS FOR ABANDONING THE URIC ACID THEORY OF GOUT. British Medical Journal, 1, 127–129.

West, S. (1911). A Clinical Lecture ON GRANULAR KIDNEY AND ITS SURPRISES. British Medical Journal, 1, 1099–1101.

Wright, C. (1975). An explanation for some aspects of the behaviour of congested road traffic in terms of a simple model. Transportation Research, 9, 267–273.

Wright, S., Chapman, P., Frampton, C., O’Donnell, J., & Raja, R. (2017). The Journal of Rheumatology Management of Gout in a Hospital Setting : A Lost Opportunity and Lisa Stamp.

Xu, H., Qin, H., Hua, Y., & Dalbeth, N. (2023). Contributions of joint damage-related events to gout pathogenesis: new insights from laboratory research. Annals of the Rheumatic Diseases, 82, 1511–1515.

Yi-nu, M., & Xin, O. (2009). Progress of High Methylation On Cerical Cancer Related Gene Promoter. Progress in Modern Biomedicine.

Yun-fe, H. (2015). Investigation of the abnormal of serum carbohydrate antigen 724 level in patients with gout. Chinese Journal of Health Laboratory Technology.

Yung-Chen, Lin, C.-S., Hong, C.-F., Lee, D. J., Sun, C., & Lin, H.-H. (2019). Design of a Clinical Decision Support System for Predicting Erectile Dysfunction in Men Using NHIRD Dataset. IEEE Journal of Biomedical and Health Informatics, 23, 2127–2137.

Zeidan, J., Fombonne, E., Scorah, J., Ibrahim, A., Durkin, M., Saxena, S., Yusuf, A., Shih, A., & Elsabbagh, M. (2022). Global prevalence of autism: A systematic review update. Autism Research, 15, 778–790.

Zhang, J., Jin, C., Ma, B., Sun, H., Chen, Y., Zhong, Y., Han, C., Liu, T., & Li, Y. (2023). Global, regional and national burdens of gout in the young population from 1990 to 2019: a population-based study. RMD Open, 9.

Zhu, B., Yi-Wang, Zhou, W., Jin, S., Shen, Z., Zhang, H., Zhang, X., Ding, X., & Li, Y. (2022). Trend dynamics of gout prevalence among the Chinese population, 1990-2019: A joinpoint and age-period-cohort analysis. Frontiers in Public Health, 10.

Ziegler, A., Ladman, B., Dunn, P., Schneider, A., Davison, S., Miller, P., Lu, H., Weinstock, D., Salem, M., Eckroade, R., & Gelb, J. (2002). Nephropathogenic Infectious Bronchitis in Pennsylvania Chickens 1997–2000. Avian Diseases, 46, 847–858.

Zimmerman, H., Bhagwat, M., Laranger, R., Padnick-Silver, L., & LaMoreaux, B. (2023). AB1240 PERCEPTIONS OF GOUT AND ITS MANAGEMENT PATTERNS: FINDINGS FROM SURVEY AND STRUCTURED INTERVIEWS WITH PRIMARY CARE PHYSICIANS AND RHEUMATOLOGISTS. Annals of the Rheumatic Diseases.

Zobbe, K., Prieto-Alhambra, D., Cordtz, R., Højgaard, P., Hindrup, J. S., Kristensen, L., & Dreyer, L. (2019). Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study. Rheumatology.